Bank of America
WGBS

Bank of America’s WaferGen Bio-systems, Inc. WGBS Stock Holding History

Bank of America’s Portfolio WGBS Stock Details WGBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-586
Closed -$2K – 7612
2016
Q3 		$2K Buy
586
+79
+16% +$354 ﹤0.01% 6889
2016
Q2 		$2K Hold
507
– – ﹤0.01% 6952
2016
Q1 		$2K Hold
507
– – ﹤0.01% 6821
2015
Q4 		$2K Sell
507
-5,622
-92% -$27.9K ﹤0.01% 7148
2015
Q3 		$42K Buy
6,129
+5,622
+1,109% +$51.6K ﹤0.01% 6020
2015
Q2 		$8K Hold
507
– – ﹤0.01% 6684
2015
Q1 		$11K Hold
507
– – ﹤0.01% 6283
2014
Q4 		$8K Buy
507
+7
+1% +$131 ﹤0.01% 7147
2014
Q3 		$11K Buy
+500
New +$11.1K ﹤0.01% 7304

Other funds holding WGBS

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Bank of America's WGBS Position: Q4 2016 in Review

Bank of America sold out of WaferGen Bio-systems, Inc. (WGBS) in Q4 2016, closing a stake of 586 shares — an estimated $2K sold.

Bank of America first reported a position in WGBS in Q3 2014 and held it in 9 quarters. The position peaked at $42K in Q3 2015. 9 funds tracked by Wall St. Rank hold WGBS as of Q4 2016.

  • Bank of America reported no remaining WaferGen Bio-systems, Inc. position as of Q4 2016 after selling out during the quarter.
  • Bank of America sold 586 WaferGen Bio-systems, Inc. shares in Q4 2016, an estimated $2K.
  • Bank of America first reported a position in WaferGen Bio-systems, Inc. in Q3 2014 and held it in 9 quarters.
  • Bank of America's WaferGen Bio-systems, Inc. position peaked at $42K in Q3 2015.
  • 9 funds tracked by Wall St. Rank held WaferGen Bio-systems, Inc. as of Q4 2016.

Based on Bank of America's 13F filing for Q4 2016, filed 14 Feb 2017.